Purchase Order 75D30124P19063

The Centers for Disease Control and Prevention has awarded a $300,000 firm fixed price purchase order to Nanocomposix, Inc. for lateral flow assay devices. The contract has no set-aside designation and runs through September 2023. Nanocomposix will deliver the requested lateral flow assay products to CDC under this contract. As a manufacturer of engineered nanoparticles located in San Diego, California, Nanocomposix has extensive experience providing lateral flow assays, gold nanoparticles,...

The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a $249,950.00 firm fixed price purchase order to Nanocomposix, Inc. for the development of a Lateral Assay Device. Nanocomposix is a manufacturer of engineered nanoparticles that has previously supported federal contracts for lateral flow assays, vaccines, and diagnostics. The contract is not set aside for any socioeconomic program. Nanocomposix has produced pilot lots for clinical trials...

This firm fixed price purchase order contract, awarded by the Centers for Disease Control and Prevention (CDC) to Nanocomposix, Inc., is for $150,000.00 and is for research and development under the Small Business Innovation Research (SBIR) program. The contract is not set aside for a specific business type. Nanocomposix is a small business that manufactures engineered nanoparticles and has previously performed prime contracts and subcontractor work for the National Institutes of Health, Food...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order contract to Nanotek LLC for the delivery of nano particles. The contract has a ceiling value of $24,600.00 and a completion date of July 1, 2022. This contract is part of the CDC's NANO PARTICLES major program and was awarded on June 2, 2022 without the use of a set-aside. Nanotek LLC is a for-profit limited liability company that is registered in the System for Award Management (SAM.gov)...

The Centers for Disease Control and Prevention awarded a $176,114 firm fixed price purchase order to Precision Nanosystems US Inc. to deliver a NanoAssembler Ignite Instrument and NanoAssembler Spark Instrument. As a prime contractor supporting CDC programs, Precision Nanosystems will provide nanotechnology products to assist the agency in advancing biomedical research and public health initiatives. No subcontractors or set aside designations were indicated. The contract has a period of...

This is a $1,500,000.00 Firm Fixed Price contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The objective of the contract is to develop cytomegalovirus (CMV) IgG and IgM lateral flow assays required to support a large-scale CMV vaccination trial. Nanocomposix has prior experience providing lateral flow assay devices,...

Nanocellect Biomedical Inc., a San Diego-based biotechnology company specializing in advanced cell analysis and sorting equipment, received a $55,000 firm fixed-price purchase order from the Centers for Disease Control and Prevention (CDC) Pittsburgh division on April 27, 2024. The contract is designated as a Base Year Sole Award with no set-aside provisions and will be performed in San Diego, California, with completion anticipated by April 26, 2029. As the original equipment manufacturer of...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $92,772.80 firm-fixed-price purchase order contract to Luminex Corporation, a manufacturer of biological testing technologies and diagnostic solutions. The contract does not have a set-aside designation. Luminex has previously provided immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing products to various federal agencies, including the CDC, Department of Veterans...

This is a $54,350.44 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corp, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the procurement of Luminex's proprietary MagPlex-C Microsphere Beads, which are a specialized laboratory instrument used in the CDC's serological assays to quantify antibodies for public health surveillance. The CDC requires these beads due to their...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Nanocomposix, Inc., a manufacturer of engineered nanoparticles, to build a proof of concept lateral flow rapid diagnostic to identify the serological status of individuals with respect to cytomegalovirus (CMV). The contract, valued at $224,887.00, requires the contractor to characterize...